Back to Search
Start Over
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
- Source :
- Journal of Clinical Oncology. 26:2054-2054
- Publication Year :
- 2008
- Publisher :
- American Society of Clinical Oncology (ASCO), 2008.
-
Abstract
- 2054 Background: Elderly patients have glioblastomas (GBM) that are aggressive and poorly responsive to treatment. They are also prone to the side effects of treatment of GBM. Methods: To shed light on the treatment of elderly patients with GBM, we reviewed the treatment toxicities and survival of patients 65 years of age or older who were treated with chemoradiotherapy, which is the new standard of care for GBM in younger patients. Results: Thirty-nine patients at a single cancer center in Canada met the eligibility criteria for this retrospective study. Nineteen patients were treated initially with TMZ and radiotherapy and 20 others were treated with radiotherapy alone (only two had TMZ subsequently). Eight patients in the chemoradiotherapy group (42%) experienced grade III or IV toxicity versus none in the radiotherapy group. The median overall survival in the chemoradiotherapy group was 8.5 months (range, 2.0–24.7 months) versus 5.2 months (range, 1.5–14.2 months) in the radiotherapy group, an apparen...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 26
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........f88196132561df9aade7e3ea32ab487b